Skip to main content

Table 2 Test Results of BMSCs Surface Molecular Marker (CD45, CD90)

From: Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model

Surface marker F0-2 F0-3 F0-4 F0-5 F0-6 F0-7 F0-8 F0-9 F1-7 F2-7 F3-7
CD45 (%) 65.3 68.4 0.1 1.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0
CD90 (%) 5.8 3.5 6.9 12.0 22.8 61.8 83.8 89.0 94.0 94.9 97.0